Your browser doesn't support javascript.
loading
Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia.
Zhao, Liansheng; Wang, Huijuan; Zhang, Yamin; Wei, Jinxue; Ni, Peiyan; Ren, Hongyan; Li, Gang; Wang, Qiang; Reynolds, Gavin P; Yue, Weihua; Deng, Wei; Yan, Hao; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Li, Yinfei; Yu, Hua; Zhang, Hongyan; Ma, Xin; Yang, Fude; Li, Lingjiang; Wang, Chuanyue; Wang, Huiyao; Li, Xiaojing; Guo, Wanjun; Hu, Xun; Tian, Yang; Ma, Xiaohong; Coid, Jeremy; Zhang, Dai; Chen, Chao; Li, Tao.
Afiliação
  • Zhao L; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Wang H; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Zhang Y; The National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, 710069, China.
  • Wei J; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Ni P; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Ren H; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Li G; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Wang Q; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Reynolds GP; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Yue W; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Deng W; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Yan H; Shaanxi Lifegen Co., Ltd, Xi'an, 712000, China.
  • Tan L; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Chen Q; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Yang G; Biomolecular Science Research Centre, Sheffield Hallam University, Sheffield, S11WB, UK.
  • Lu T; Peking University Sixth Hospital (Institute of Mental Health), Beijing, 100083, China.
  • Wang L; National Clinical Research Center for Mental Disorders and Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, 100871, China.
  • Zhang F; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Yang J; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Li K; Peking University Sixth Hospital (Institute of Mental Health), Beijing, 100083, China.
  • Lv L; National Clinical Research Center for Mental Disorders and Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, 100871, China.
  • Tan Q; Second Xiangya Hospital, Central South University, Changsha, 410011, China.
  • Li Y; Beijing Anding Hospital, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, 100088, China.
  • Yu H; Beijing HuiLongGuan Hospital, Beijing, 102200, China.
  • Zhang H; Peking University Sixth Hospital (Institute of Mental Health), Beijing, 100083, China.
  • Ma X; National Clinical Research Center for Mental Disorders and Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, 100871, China.
  • Yang F; Peking University Sixth Hospital (Institute of Mental Health), Beijing, 100083, China.
  • Li L; National Clinical Research Center for Mental Disorders and Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, 100871, China.
  • Wang C; Wuxi Mental Health Center, Nanjing Medical University, Wuxi, 214121, China.
  • Wang H; Institute of Mental Health, Tianjin Anding Hospital, Tianjin, 300222, China.
  • Li X; Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, 300052, China.
  • Guo W; Hebei Mental Health Center, Baoding, 071000, China.
  • Hu X; Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453003, China.
  • Tian Y; Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
  • Ma X; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Coid J; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Zhang D; Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Chen C; West China Brain Research Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Li T; Peking University Sixth Hospital (Institute of Mental Health), Beijing, 100083, China.
Neurosci Bull ; 35(6): 1102-1105, 2019 12.
Article em En | MEDLINE | ID: mdl-31571100
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Receptores de Dopamina D2 / Receptor 5-HT2A de Serotonina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Neurosci Bull Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Singapura
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Receptores de Dopamina D2 / Receptor 5-HT2A de Serotonina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Neurosci Bull Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Singapura